SCHEMBL6597257

SCHEMBL6597257

Cc1c(-c2cc3ccccc3o2)oc(=O)c(C)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.50
HPGD P15428 4/20 0.49
TYR P14679 1/20 0.49
DAO P14920 1/20 0.49
AKR1B1 P15121 1/20 0.49
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
POLB P06746 2/20 0.46
CTDSP1 Q9GZU7 1/20 0.46
MAOB P27338 4/20 0.45
MAOA P21397 3/20 0.45
CA12 O43570 2/20 0.44
CA9 Q16790 2/20 0.44
CYP1A2 P05177 2/20 0.44
NT5E P21589 1/20 0.44
ALOX5 P09917 1/20 0.44
ERN1 O75460 1/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
ALDH1A1 P00352 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6589038 0.86 MAOB (0.46) KDM4EHPGDTYRDAOAKR1B1
SCHEMBL27535017 0.86 KDM4E (0.43) KDM4EHPGDTYRDAOAKR1B1
SCHEMBL6592701 0.85 ERN1 (0.46) KDM4EHPGDTYRDAOAKR1B1
SCHEMBL6592657 0.85 HPGD (0.43) KDM4EHPGDTYRDAOAKR1B1
SCHEMBL6593445 0.85 KDM4E (0.44) KDM4EHPGDTYRDAOAKR1B1
SCHEMBL6594570 0.85 KDM4E (0.44) KDM4EHPGDTYRDAOAKR1B1
SCHEMBL6591976 0.85 HPGD (0.43) KDM4EHPGDTYRDAOAKR1B1
SCHEMBL6593448 0.84 HSD17B3 (0.55) KDM4EHPGDTYRAKR1B1MEN1
SCHEMBL6593518 0.84 ESR1 (0.50) KDM4EHPGDMAOBMAOACA12
SCHEMBL6596321 0.84 KDM4E (0.41) KDM4EHPGDTYRDAOAKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1063235-B1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LTD (JP) 2004-05-12 EP disclosed
US-20030186976-A1 Benzofurylpyrone derivatives TEIJIN LIMITED, MICROBIAL CHEMISTRY RESEARCH FOUNDATION 2003-10-02 US disclosed
US-6589984-B1 Blood cholesterol and triglycerides (TG) themselves are generally insoluble in blood, and they exist as lipoproteins by binding with apolipoproteins. In the body, triglycerides are biosynthesized primarily in the liver from acetyl CoA as TEIJIN LIMITED (JP) 2003-07-08 US disclosed
CN-1299359-A Benzofurylpyrone derivatives TEIJIN LTD (JP) 2001-06-13 CN disclosed
EP-1063235-A1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LIMITED (JP) 2000-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030186976-A1 Benzofurylpyrone derivatives PLIN5, ACSL5, PLIN1 KDM4E 1274/4885HPGD 926/4885TYR 4052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.